Cargando…

EGFR Amplification and Glioblastoma Stem-Like Cells

Glioblastoma (GBM), the most common malignant brain tumor in adults, contains a subpopulation of cells with a stem-like phenotype (GS-cells). GS-cells can be maintained in vitro using serum-free medium supplemented with epidermal growth factor, basic fibroblast growth factor-2, and heparin. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liffers, Katrin, Lamszus, Katrin, Schulte, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468289/ https://www.ncbi.nlm.nih.gov/pubmed/26136784 http://dx.doi.org/10.1155/2015/427518

Ejemplares similares

EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise
por: Westphal, Manfred, et al.
Publicado: (2017)

Chimeric Antigen Receptor T Cells in Glioblastoma—Current Concepts and Promising Future
por: Kringel, Rebecca, et al.
Publicado: (2023)

Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma
por: Hu, Leland S., et al.
Publicado: (2021)

EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells
por: Struve, Nina, et al.
Publicado: (2015)

EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco
por: Senhaji, Nadia, et al.
Publicado: (2017)

EGFR Pathway Expression Persists in Recurrent Glioblastoma Independent of Amplification Status
por: Dhawan, Andrew, et al.
Publicado: (2023)

Expression of Eukaryotic Initiation Factor 5A and Hypusine Forming Enzymes in Glioblastoma Patient Samples: Implications for New Targeted Therapies
por: Preukschas, Michael, et al.
Publicado: (2012)

Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients
por: Bieńkowski, Michał, et al.
Publicado: (2013)

Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma
por: Walentynowicz, Kacper A., et al.
Publicado: (2023)

Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma
por: Dührsen, Lasse, et al.
Publicado: (2019)

The miR-183/96/182 cluster is upregulated in glioblastoma carrying EGFR amplification
por: Schneider, Björn, et al.
Publicado: (2022)

The Role of EGFR Amplification in Deep Venous Thrombosis Occurrence in IDH Wild-Type Glioblastoma
por: Kaye, Brandon, et al.
Publicado: (2023)

Mechanisms of EGFR Resistance in Glioblastoma
por: Pan, Peter C., et al.
Publicado: (2020)

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
por: Talasila, Krishna M., et al.
Publicado: (2013)

Glioblastoma Stem-Like Cells—Biology and Therapeutic Implications
por: Gürsel, Demirkan B., et al.
Publicado: (2011)

Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells
por: Wolpert, Fabian, et al.
Publicado: (2015)

Correlation between EGFR Amplification and the Expression of MicroRNA-200c in Primary Glioblastoma Multiforme
por: Serna, Eva, et al.
Publicado: (2014)

Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma
por: Muñoz-Hidalgo, Lisandra, et al.
Publicado: (2019)

Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts
por: Lee, Kyoungmin, et al.
Publicado: (2020)

A multicenter, phase II trial of GC1118, a novel anti‐EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
por: Choi, Seung Won, et al.
Publicado: (2023)

Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue
por: Wallenborn, Marco, et al.
Publicado: (2020)

Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme
por: William, Doreen, et al.
Publicado: (2017)

Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
por: Fontanilles, Maxime, et al.
Publicado: (2020)

Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells
por: Rehbein, Sarah, et al.
Publicado: (2023)

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
por: Scharpenseel, Heather, et al.
Publicado: (2019)

EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
por: Krusche, Benjamin, et al.
Publicado: (2016)

PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells
por: Seifert, Carolin, et al.
Publicado: (2021)

Next generation sequencing and molecular imaging identify EGFR mutation and amplification in a glioblastoma multiforme patient treated with an EGFR inhibitor: a case report
por: Zhou, Ke, et al.
Publicado: (2017)

An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma
por: Rodriguez, Silvia Mara Baez, et al.
Publicado: (2023)

Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like Cells
por: Guelfi, Sophie, et al.
Publicado: (2016)

Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study
por: Zirjacks, Lisa, et al.
Publicado: (2021)

EGFR amplification induces sensitivity to antiEGFR therapy in pancreatic acinar cell carcinoma
por: Richard, Corentin, et al.
Publicado: (2018)

Novel Peripherally Derived Neural‐Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas
por: Birbrair, Alexander, et al.
Publicado: (2016)

Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma
por: Furgason, John M., et al.
Publicado: (2015)

Cancer stem cells in glioblastoma
por: Lathia, Justin D., et al.
Publicado: (2015)

CRISPR-to-Kill (C2K)–Employing the Bacterial Immune System to Kill Cancer Cells
por: Głów, Dawid, et al.
Publicado: (2021)

Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma
por: Azuaje, Francisco, et al.
Publicado: (2015)

Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma
por: Pala, Andrej, et al.
Publicado: (2012)

Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?
por: Dewdney, Brittany, et al.
Publicado: (2022)

CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
por: Han, Jianfeng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_065cd65jvbajjjgus3mmc0n9mj